SEC Form 4 · accession 0001140361-16-088281
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward P. Feener
Officer — Chief Scientific Officer
Period of report
Nov 28, 2016
Accepted (ET)
Nov 30, 2016 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $10.21 | Nov 28, 2016 | A | 20,055 | A | — | Nov 27, 2026 | Common Stock | 20,055 | 20,055 | D |
Explanation of responses
- F1The option vests 1/48th of the total shares monthly beginning November 28, 2016.